Colitis eosinofílica: una entidad aparte
| dc.contributor.author | Rodrigo Quera | |
| dc.contributor.author | Paulina Núñez | |
| dc.contributor.author | Christian von Mühlenbrock | |
| dc.contributor.author | José Joaquín Caerols Pérez | |
| dc.contributor.author | Luis Fernando Herbozo Contreras | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-22T19:17:41Z | |
| dc.date.available | 2026-03-22T19:17:41Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Eosinophilic colitis (EoC), a rare immune-mediated disease that is part of the eosinophilic gastrointestinal diseases, is characterized by the presence of an eosinophilic infiltrate in the colonic wall in symptomatic patients.Before considering the diagnosis of EoC, other diseases associated with colonic eosinophilia should be ruled out, such as parasitic infections, drugs, chronic immune-mediated diseases, and neoplasms.The symptoms of EoC are variable and non-specific, being abdominal pain and diarrhea the most common.Although systemic corticosteroids and budesonide have demonstrated their efficacy, these drugs have only been evaluated in case series studies and clinical case reports.Herein, we discuss the clinical strategy for diagnosis, therapy selection, and follow-up of EoC. | |
| dc.identifier.doi | 10.46613/gastrolat2024001-05 | |
| dc.identifier.uri | https://doi.org/10.46613/gastrolat2024001-05 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/75204 | |
| dc.language.iso | es | |
| dc.relation.ispartof | Revista Gastroenterología Latinoamericana | |
| dc.source | Universidad de Los Andes | |
| dc.subject | Philosophy | |
| dc.subject | Humanities | |
| dc.subject | Mathematics | |
| dc.title | Colitis eosinofílica: una entidad aparte | |
| dc.type | article |